September 20, 2021
A New Jersey federal judge on Monday adopted a recommendation to dismiss a shareholder derivative class action that alleged executives of Canadian pharmaceutical company Bausch Health Cos. Inc. tried to cover up a price-gouging scheme.
April 22, 2020
Bausch Health Cos. Inc. executives urged a New Jersey federal judge to toss a shareholder derivative suit over their alleged cover-up of the Canadian pharmaceutical company's purported price-gouging scheme, arguing that the case belongs in British Columbia.